Samaritan Pharmaceuticals: "We LIV....to Save Lives."

Samaritan Pharmaceuticals Inc. a developer of innovative drugs, announced today, its Alzheimer's drug SP233, recently registered as Caprospinol, showed no toxic effects in standard preclinical assays used to evaluate its safety. This is an important finding for SP233's future as a possible life-saving, memory-saving, Alzheimer's drug. Samaritan has concluded a number of preclinical studies of SP233, in preparation to file an investigational new drug (IND) application, with the FDA.
While the jury is still out as to the exact cause of Alzheimer's, most researchers think a buildup of the protein beta-amyloid in the brain is what causes the disease. So far, each preclinical study has given Samaritan hope that SP233 holds promise to exert neuroprotective properties against beta-amyloid toxicity.
Dr. Greeson, CEO of Samaritan stated, "We are wrapping up the last preclinical study to file an IND with the FDA, it's been a complex process but we are almost there, it's exciting. We are cautiously optimistic the FDA will grant us an IND and if so, SP233 would be one of the few drugs to be tested in humans that could actually treat Alzheimer's, not just alleviate its symptoms."

Samaritan is the Little Biotech That Could Be Remembered for ...Genetic Engineering News - Larchmont,NY,USAWhile the jury is still out as to the exact cause of Alzheimer's, most researchers think a buildup of the protein beta-amyloid in the brain is what causes the ...
Reduced insulin in the brain triggers Alzheimer's degenerationEurekAlert (press release) - Washington,DC,USA... They found that amyloid beta deposits in vessels and plaques did build up in the brain, and they suggest that these abnormalities occurred due to increased ...
Alzheimer's Pathology Linked To Single EnzymeMedPage Today - Little Falls,NJ,USA... combined with its effects on APP processing and A-beta production in culture and in animals, suggest a novel understanding of the way amyloid plaques form. ...

The choroid plexus prevents build up of plaque related to ...News-Medical.net - Sydney,Australia... Researchers had already known that the cerebrospinal fluid in the brains of Alzheimer's patients contains abnormally high quantities of beta-amyloid fragments. ...